Worthy New Immunotherapy Clinical Trial Opens at Johns Hopkins University for Men Thinking of Surgery
The exciting thing about Provenge is not only the real survival advantage that it offers with minimal side effects, but that it is a proof of concept treatment that is heralding in the potential future of many other immunotherapies. Today, we have two new possible treatments in active phase 3 trials, Prostvac and Yervoy. [...]